Onyema Ogbuagu
American-Nigerian physician and medical researcher
Onyema Ogbuagu's AcademicInfluence.com Rankings
Download Badge
Biology Philosophy
Onyema Ogbuagu's Degrees
- Bachelors Medicine University of Calabar
Why Is Onyema Ogbuagu Influential?
(Suggest an Edit or Addition)According to Wikipedia, Onyema Eberechukwu Ogbuagu is an American-born infectious diseases physician, educator, researcher, and clinical trial investigator, who was raised and educated in Nigeria. He is an associate professor at Yale School of Medicine in New Haven, CT and is the director of the Yale AIDS Program clinical trials unit. His research contributions have focused on HIV/AIDS prevention and COVID-19 vaccination and treatment clinical trials. He switched his focus at the beginning of the 2019 COVID pandemic and participated as a principal investigator on the Pfizer-BioNtech COVID-19 vaccine trials and the Remdesivir SIMPLE trial in 2020 and 2021. In pursuit of his global health component of his career, Ogbuagu also supports postgraduate physician medical education programs in low and middle income countries in sub-Saharan Africa in Rwanda and Liberia as well as HIV treatment programs in Liberia .
Onyema Ogbuagu's Published Works
Published Works
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. (2020) (901)
- High prevalence of antimicrobial resistance among common bacterial isolates in a tertiary healthcare facility in Rwanda. (2015) (82)
- De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report (2022) (55)
- HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system (2018) (41)
- De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report (2021) (34)
- Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-naïve human immunodeficiency virus–infected patients compared to non-nucleoside and protease inhibitor–based regimens in a real-world clinical setting (2018) (32)
- Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study (2022) (23)
- Mitochondrial DNA somatic mutation burden and heteroplasmy are associated with chronological age, smoking, and HIV infection (2019) (23)
- Five-Year Antimicrobial Susceptibility Trends Among Bacterial Isolates from a Tertiary Health-Care Facility in Kigali, Rwanda. (2016) (21)
- Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda (2018) (20)
- Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. (2021) (20)
- Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection (2018) (19)
- Prevalence and Correlates of Unhealthy Alcohol and Drug Use Among Men Who Have Sex with Men Prescribed HIV Pre-exposure Prophylaxis in Real-World Clinical Settings (2018) (19)
- Clinical Profile and Outcome of Patients with Acute Kidney Injury Requiring Hemodialysis: Two Years' Experience at a Tertiary Hospital in Rwanda (2018) (16)
- Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers (2019) (15)
- Reaching the Unreached: Treatment as Prevention as a Workable Strategy to Mitigate HIV and Its Consequences in High-Risk Groups (2014) (15)
- Qualitative assessment of anti‐SARS‐CoV‐2 spike protein immunogenicity (QUASI) after COVID‐19 vaccination in older people living with HIV (2021) (15)
- Concurrent cryptococcal meningitis and disseminated tuberculosis occurring in an immunocompetent male (2016) (13)
- Dolutegravir/rilpivirine for the treatment of HIV-1 infection (2018) (13)
- Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations (2017) (12)
- A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding? (2021) (12)
- Drug interactions between buprenorphine, methadone and hepatitis C therapeutics (2016) (11)
- Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicity. (2015) (10)
- Unusual presentation of disseminated Nocardia abscessus infection in a patient with AIDS (2016) (10)
- Implementing a Comprehensive HCV Clinic within an HIV Clinic: A Model of Care for HCV Micro-elimination. (2019) (9)
- Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection (2019) (9)
- Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients (2019) (8)
- Implementing a Comprehensive Hepatitis C Virus (HCV) Clinic Within a Human Immunodeficiency Virus Clinic: A Model of Care for HCV Microelimination (2019) (8)
- Extensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and Strategies (2014) (7)
- Steroid-exacerbated HIV-associated cutaneous Kaposi’s sarcoma immune reconstitution inflammatory syndrome: ‘Where a good intention turns bad’ (2016) (7)
- The Changing Face of HIV Care: Expanding HIV Training in an Internal Medicine Residency Program. (2018) (6)
- Successful sofosbuvir lead-in monotherapy for the treatment of hepatitis C virus (HCV) infection in a pregnant woman living with HIV (2019) (6)
- Rilpivirine, emtricitabine and tenofovir alafenamide: single-tablet combination for the treatment of HIV-1 infection in selected patients (2016) (6)
- Transmission risk of respiratory viruses in natural and mechanical ventilation environments: implications for SARS-CoV-2 transmission in Africa (2020) (6)
- Mycobacterium marinum: nodular hand lesions after a fishing expedition (2020) (5)
- Fatal multiple deer tick-borne infections in an elderly patient with advanced liver disease (2015) (5)
- Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP) (2022) (5)
- 1962. Renal Outcomes for Participants Taking F/TAF vs. F/TDF for HIV PrEP in the DISCOVER Trial (2019) (4)
- Fatal cryptococcal meningitis in an AIDS patient complicated with immune reconstitution syndrome refractory to prolonged amphotericin B treatment (2018) (3)
- 1585. Efficacy and safety of long-acting subcutaneous lenacapavir in heavily treatment-experienced people with multi-drug resistant HIV: Week 52 results (2022) (3)
- Safety and immunogenicity of a SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in healthy adults: interim findings from a phase 2, randomised, dose-finding, multi-centre study (2021) (3)
- 216: Unique Etiology of Hypercalcemia in Male to Female Transgender Patients (2010) (2)
- Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH) (2022) (2)
- HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report (2023) (2)
- Latent Mycobacterium tuberculosis Infection. (2015) (2)
- Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients. (2017) (1)
- Facing COVID-19 in Liberia: Adaptations of the Resilient and Responsive Health Systems Initiative (2021) (1)
- Obstructive uropathy as initial presentation of genitourinary tuberculosis and masquerading as a postsurgical complication (2017) (1)
- Histoplasmosis in a Nonendemic Area: An Often Unrecognized Disease (2016) (1)
- SEQUENTIAL LOW COST INTERVENTIONS DOUBLE HAND HYGIENE RATES AMONG MEDICAL TEAMS IN A RESOURCE LIMITED SETTING. RESULTS OF A HAND HYGIENE QUALITY IMPROVEMENT PROJECT CONDUCTED AT UNIVERSITY TEACHING HOSPITAL OF KIGALI (CHUK), KIGALI, RWANDA. (2014) (1)
- Five-Year Antimicrobial Susceptibility Trends Among Bacterial Isolates from King Faisal Hospital Tertiary Health-Care Facility in Kigali, Rwanda (2017) (1)
- Correction: Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda (2019) (1)
- Single-pill regimens for HIV-1 infection. (2014) (1)
- Dolutegravir hypersensitivity reaction: the need for strengthening pharmacovigilance systems with optimization of antiretroviral therapy in HIV programs in resource-limited settings: case report (2022) (1)
- CD8 T-Cell Lymphocytosis and Associated Clinical Syndromes in HIV-Infected Patients. (2015) (0)
- Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options. (2023) (0)
- Disseminated tuberculosis manifesting as cholestasis in a patient with AIDS: a presentation to remember (2014) (0)
- Comparison of Time to Viral Suppression Among Treatment-Naïve HIV-Infected Adults Initiating Combination Antiretroviral Therapy by Antiretroviral Regimen Class (2017) (0)
- 848. Approaches to Optimize Recruitment of Historically Underrepresented Black and Hispanic/LatinX MSM, Transgender, and Gender Non-binary Individuals into the Lenacapavir for PrEP (PURPOSE 2) Trial (2021) (0)
- Early infant diagnosis of HIV infection at the John F. Kennedy Medical Center, Monrovia, Liberia (2022) (0)
- Longer-Term Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide Versus Emtricitabine and Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Week 96 Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial (2021) (0)
- LB1577. Outcomes of Pregnant Women Exposed to Sotrovimab for the Treatment of COVID-19 in the Omicron Predominant Era (PRESTO) (2022) (0)
- High HIV Detection in a Tertiary Facility in Liberia: Implications and Opportunities (2021) (0)
- Answer to December 2017 Photo Quiz (2017) (0)
- Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO) (2023) (0)
- 599. Expanding HIV Training in Internal Medicine Residency Program: A Prospect to Meet the HIV Workforce Demand (2018) (0)
- 1261. Alarming High Rate of HIV Detected by Testing and Prevention Opportunities: Observations From the Largest HIV Program in Liberia (2019) (0)
- 1558Clinico-demographic Profile and Treatment Outcomes of Pediatric Participants of a Large Outpatient HIV Clinic in Kigali, Rwanda (2014) (0)
- Late neurosyphilis and VZV meningoencephalitis coinfection (2021) (0)
- 2234. Implementing a Co-located HCV Clinic Within an HIV Clinic: Four Year Experience (2018) (0)
- Su1395 Eligibility of a Real World Population for Phase 3 Clinical Trials for Chronic Hepatitis C Infection (2015) (0)
- Acute kidney injury due to myoglobin cast nephropathy in the setting of coronavirus disease 2019-mediated rhabdomyolysis: a case report (2022) (0)
- A Matched Case-Control Study of Clinical Outcomes of Patients with Daptomycin Non-Susceptible and Daptomycin Susceptible Vancomycin-Resistant Enterococcal Bacteremia (2016) (0)
- Predictors of Mortality from Sepsis among an African Patient Cohort: A Prospective Study from Two Tertiary Healthcare Facilities in Kigali, Rwanda. (2015) (0)
- Trends in Tuberculosis Cases at a Connecticut Hospital, 2005 – 2014 (2015) (0)
- Infections in HIV-Infected Patients (2018) (0)
- Morning report in Kigali - November 20, 2013. (2014) (0)
- 1328. Post-War and Post-Ebola HIV Care Continuum in a Liberian Academic Center: Fresh Insights and Trends Over 5-Year Period (2019) (0)
- Curbing Ebola infections among healthcare workers in West Africa: unconventional strategies needed (2014) (0)
- Correction: HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report (2023) (0)
- Race and ethnicity do not impact eligibility for remdesivir: A single-center experience (2021) (0)
- My Scariest Experience as a Doctor (2011) (0)
- The Natural History of FIB-4 Score Progression Among HIV/Hepatitis C Virus (HCV)–Coinfected Adults in an Outpatient Clinic (2016) (0)
- Transforming medical education in Liberia through an international community of inquiry (2023) (0)
- Photo Quiz: Peripheral Blood Smear in a Ugandan Refugee (2017) (0)
- Gaps and Opportunities in HIV Service Delivery in High Volume HIV Care Centers in Liberia: Lessons From the Field (2021) (0)
- Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients (2017) (0)
This paper list is powered by the following services:
Other Resources About Onyema Ogbuagu
What Schools Are Affiliated With Onyema Ogbuagu?
Onyema Ogbuagu is affiliated with the following schools: